Texas 2021 - 87th Regular

Texas House Bill HB3951

Caption

Relating to health benefit plan coverage for certain tests to detect prostate cancer.

Impact

The implications of HB 3951 on state laws are notable. By removing financial barriers associated with prostate cancer screening tests, the bill aims to enhance public health outcomes by encouraging more individuals to undergo early detection testing. This change is expected to lead to early diagnosis and intervention, which in turn can reduce the severity of cancer cases and associated healthcare costs in the long term. Such legislative measures may prompt similar considerations for insurance coverage regarding other significant health screenings in the future.

Summary

House Bill 3951 aims to amend the Insurance Code to enhance health benefit plan coverage specific to tests for prostate cancer detection. This legislation is particularly significant as it intends to eliminate co-pays, deductibles, or any form of cost-sharing for these essential health services, thereby promoting greater accessibility for patients at risk of prostate cancer. The bill underscores the Texas legislature's commitment to prioritizing preventive health measures in areas where early detection can notably impact treatment outcomes.

Sentiment

The sentiment surrounding HB 3951 has been largely positive, with many legislators and health advocates voicing strong support for the bill. Proponents argue that increasing access to prostate cancer screenings demonstrates a proactive public health strategy. However, skepticism exists among some stakeholders regarding the insurance industry's capacity and willingness to accommodate these changes without impacting the overall cost structure of health plans. This tension reflects wider conversations about healthcare affordability and provider reimbursement.

Contention

Although the bill has garnered significant support, it is not without points of contention. Some critics have raised concerns regarding the financial implications for insurance providers under the new regulations and whether they might lead to increased premiums for consumers as a trade-off. The discussion has also highlighted considerations about how such blanket coverage mandates affect the sustainability of health plans, thus stimulating dialogue around cost management and the economics of healthcare delivery in Texas.

Companion Bills

TX SB1539

Same As Relating to health benefit plan coverage for certain tests to detect prostate cancer.

Previously Filed As

TX HB118

Relating to health benefit plan coverage for certain tests to detect prostate cancer.

TX HB3188

Relating to health benefit plan coverage for certain biomarker testing.

TX SB989

Relating to health benefit plan coverage for certain biomarker testing.

TX HB526

Relating to HIV and AIDS tests and to health benefit plan coverage of HIV and AIDS tests.

TX HB1128

Relating to availability of and benefits provided under health benefit plan coverage.

TX HB4912

Relating to availability of and benefits provided under health benefit plan coverage.

TX HB496

Relating to health benefit plan coverage for conversion therapy.

TX HB3034

Relating to notice regarding nonemergency ambulance and certain nonemergency health care coverage in health benefit plans.

TX HB3948

Relating to coverage for childhood screening, diagnosis, and treatment for dyslexia under certain health benefit plans.

TX HB389

Relating to health benefit coverage for certain fertility preservation services under certain health benefit plans.

Similar Bills

No similar bills found.